Format

Send to

Choose Destination
Clin Infect Dis. 2003 Jan 1;36(1):116-9. Epub 2002 Dec 11.

Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer.

Author information

1
Division of Internal Medicine, Department of Infectious Diseases, Infection Control, and Employee Health, University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA.

Abstract

In this prospective cohort study, minocycline-ethylenediaminetetraacetate (M-EDTA) was used as a lock solution in indwelling ports inserted in 14 children with cancer. No port infections, thrombotic events, or other adverse events were observed, compared with 10 port infections that occurred in 48 control patients whose ports were flushed with heparin. M-EDTA is a promising lock solution in long-term catheters.

PMID:
12491212
DOI:
10.1086/344952
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center